Raymond James & Associates Has $320,000 Holdings in Perrigo Company PLC (PRGO)

Raymond James & Associates lessened its stake in Perrigo Company PLC (NYSE:PRGO) by 84.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,385 shares of the company’s stock after selling 22,964 shares during the period. Raymond James & Associates’ holdings in Perrigo were worth $320,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently bought and sold shares of PRGO. FMR LLC boosted its holdings in Perrigo by 1,200.9% in the second quarter. FMR LLC now owns 5,170,125 shares of the company’s stock worth $376,954,000 after acquiring an additional 4,772,696 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Perrigo by 772.9% in the second quarter. Renaissance Technologies LLC now owns 697,508 shares of the company’s stock worth $50,855,000 after acquiring an additional 617,600 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. boosted its holdings in Perrigo by 156.6% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 574,392 shares of the company’s stock worth $41,879,000 after acquiring an additional 350,539 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Perrigo by 13.8% in the second quarter. Victory Capital Management Inc. now owns 2,801,721 shares of the company’s stock worth $204,274,000 after acquiring an additional 340,779 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. boosted its holdings in Perrigo by 96.7% in the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 512,465 shares of the company’s stock worth $37,364,000 after acquiring an additional 251,953 shares in the last quarter. Institutional investors own 83.01% of the company’s stock.

Perrigo stock opened at $69.79 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.81 and a quick ratio of 1.23. Perrigo Company PLC has a 52 week low of $67.40 and a 52 week high of $95.93. The stock has a market cap of $9.30 billion, a P/E ratio of 14.16, a PEG ratio of 2.21 and a beta of 0.84.



Perrigo (NYSE:PRGO) last released its earnings results on Thursday, August 9th. The company reported $1.22 EPS for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.01. Perrigo had a return on equity of 11.92% and a net margin of 4.77%. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same quarter in the previous year, the company posted $1.22 earnings per share. The company’s revenue was down 4.2% compared to the same quarter last year. On average, equities analysts anticipate that Perrigo Company PLC will post 4.85 EPS for the current fiscal year.

In other news, EVP Svend Andersen bought 7,200 shares of the firm’s stock in a transaction that occurred on Tuesday, August 14th. The stock was purchased at an average price of $69.43 per share, with a total value of $499,896.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 6.90% of the company’s stock.

PRGO has been the subject of several recent analyst reports. Goldman Sachs Group downgraded Perrigo from a “neutral” rating to a “sell” rating and lowered their price target for the stock from $78.00 to $74.00 in a report on Thursday, July 12th. Cantor Fitzgerald reissued a “buy” rating and issued a $107.00 price target on shares of Perrigo in a report on Wednesday, July 18th. Argus downgraded Perrigo from a “buy” rating to a “hold” rating in a report on Monday, July 30th. ValuEngine raised Perrigo from a “sell” rating to a “hold” rating in a report on Wednesday, August 8th. Finally, Deutsche Bank downgraded Perrigo from a “buy” rating to a “hold” rating and lowered their price target for the stock from $93.00 to $78.00 in a report on Friday, August 10th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the stock. Perrigo presently has a consensus rating of “Hold” and an average price target of $88.07.

Perrigo Profile

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Featured Article: What are defining characteristics of a correction?

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company PLC (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply